DARPA and Harvard ink $16 million agreement to identify and test FDA-approved drugs for COVID-19
The U.S. Defense Advanced Research Projects Agency has inked a deal with Harvard\’s Wyss Institute worth up to $16 million to use technology to identify and test FDA-approved drugs that could be used in the battle against COVID-19. According to a statement, DARPA will make use of computational drug-discovery pipelines and human organ chip technologies that …